Cantos
About Cantos
Cantos is a venture capital firm focused on investing in early-stage, deep tech companies operating at the near frontier. The firm backs founders from day one, supporting startups solving complex problems in industries such as aerospace, energy, biotechnology, and advanced manufacturing. Cantos highlights a portfolio spanning unmanned systems, high‑orbit satellites, quantum computing, biomanufacturing, and decarbonization technologies, and is positioned to back world-changing technologies from their inception. The firm emphasizes responsible stewardship of technology to advance critical industries and safeguard democratic values, with operations and portfolio rooted in North America and globally across pioneering sectors.
Recent Deals
Faeth Therapeutics Raises $25M Led by S2G Investments
Castelion Secures $350M Series B to Accelerate Hypersonic Weapon Production
Castelion Secures $350M Series B to Accelerate Hypersonic Weapon Development
Vital Lyfe Secures $24M Seed Round Led by Interlagos and General Catalyst
Adaptyx Biosciences Raises $14M Seed Round to Advance Continuous Multi‑Analyte Biowearable
Faeth Therapeutics Raises $25M Strategic Financing to Advance PIKTOR
Adaptyx Biosciences Raises $14M Seed Round Led by Interlagos Capital